GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » Beta

Response Oncology (Response Oncology) Beta : 0.56 (As of May. 03, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-03), Response Oncology's Beta is 0.56.


Response Oncology Beta Historical Data

The historical data trend for Response Oncology's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology Beta Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.33 1.14 1.11 1.33 1.69

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 2.40 1.78 1.69 1.60

Competitive Comparison of Response Oncology's Beta

For the Medical Care Facilities subindustry, Response Oncology's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Response Oncology's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's Beta distribution charts can be found below:

* The bar in red indicates where Response Oncology's Beta falls into.



Response Oncology Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Response Oncology  (GREY:ROIX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Response Oncology Beta Related Terms

Thank you for viewing the detailed overview of Response Oncology's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines